197 related articles for article (PubMed ID: 26689008)
21. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
22. [A new dementia group caused by TDP-43 abnormality].
Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
[TBL] [Abstract][Full Text] [Related]
23. The frontotemporal syndromes of ALS. Clinicopathological correlates.
Strong MJ; Yang W
J Mol Neurosci; 2011 Nov; 45(3):648-55. PubMed ID: 21809041
[TBL] [Abstract][Full Text] [Related]
24. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
25. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
Miguel L; Frébourg T; Campion D; Lecourtois M
Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
[TBL] [Abstract][Full Text] [Related]
26. [Neuropathological similarities and differences between frontotemporal lobar degeneration with ubiquitin inclusions and amyotrophic lateral sclerosis with dementia].
Tan CF; Toyoshima Y; Kakita A; Takahashi H
Brain Nerve; 2009 Nov; 61(11):1319-27. PubMed ID: 19938689
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.
Chang CF; Lee YC; Lee KH; Lin HC; Chen CL; Shen CJ; Huang CC
J Biomed Sci; 2016 Oct; 23(1):72. PubMed ID: 27769241
[TBL] [Abstract][Full Text] [Related]
28. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
[TBL] [Abstract][Full Text] [Related]
31. [Neuropathology of frontotemporal lobar degeneration with ubiquitinated inclusions].
Yoshida M
Brain Nerve; 2009 Nov; 61(11):1308-18. PubMed ID: 19938688
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of amyotrophic lateral sclerosis.
Liscic RM; Breljak D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
[TBL] [Abstract][Full Text] [Related]
33. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
34. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
Toyoshima Y; Takahashi H
Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
[TBL] [Abstract][Full Text] [Related]
35. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
36. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
37. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Vatovec S; Kovanda A; Rogelj B
Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
39. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
40. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]